Latest Breaking News On - ஆடம் கொட்டஸ் - Page 1 : comparemela.com
why putin poisoned the skripals
yourdemocracy.net.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yourdemocracy.net.au Daily Mail and Mail on Sunday newspapers.
BioVaxys gibt Ernennung eines Policy Advisor bekannt
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
BioVaxys annonce la nomination d un conseiller en politiques
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
BioVaxys Announces Appointment of Policy Advisor
USA - English
Share this article
VANCOUVER, BC, May 20, 2021 /PRNewswire/ BioVaxys Technology Corp. (CSE: BIOV) (FRA:5LB) (OTC:BVAXF)
( BioVaxys ), a biotechnology company that is advancing viral and oncology vaccine platforms as well as immuno-diagnostic products, today announced the appointment of Adam Coutts, PhD, as Policy Advisor.
Dr. Coutts is a Senior Research Fellow at Magdalene College, University of Cambridge and a Research Associate in the Department of Sociology, University of Cambridge. Dr. Coutts research focuses on the social and political determinants of health looking at how non-health sector public policies affect the health and wellbeing of vulnerable groups and how government interventions can be used to help them. Dr. Coutts holds a PhD from the Department of Sociology, University of Cambridge and has held post-doctoral fellowships at Cambridge, and the Department of Politics and Internation
Why Killer T Cells Could Boost COVID Immunity In Face Of New Variants
Financialnewsmedia.com News Commentary
PALM BEACH, Fla., May 20, 2021 /PRNewswire/ In the race against emerging coronavirus variants, researchers are looking beyond antibodies for clues to lasting protection from COVID-19. Concerns about coronavirus variants that might be partially resistant to antibody defenses have spurred renewed interest in other immune responses that protect against viruses. In particular, scientists are hopeful that T cells - a group of immune cells that can target and destroy virus-infected cells - could provide some immunity to COVID-19, even if antibodies become less effective at fighting the disease. Researchers are now picking apart the available data, looking for signs that T cells could help to maintain lasting immunity. Alongside antibodies, the immune system produces a battalion of T cells that can target viruses. Some of these, known as killer T cells, seek out and destroy c